This guideline covers assessing and managing motor neurone disease (MND). It aims to improve
care from the time of diagnosis, and covers information and support, organisation of care,
managing symptoms and preparing for end of life care....
Ward, M. M;
Deodhar, A;
Akl, E. A;
Lui, A;
Ermann, J;
Gensler, L. S;
Smith, J. A;
Borenstein, D;
Hiratzka, J;
Weiss, P. F;
Inman, R. D;
Majithia, V;
Haroon, N;
Maksymowych, W. P;
Joyce, J;
Clark, B. M;
Colbert, R. A;
Figgie, M. P;
Hallegua, D. S;
Prete, P. E;
Rosenbaum, J. T;
Stebulis, J. A;
Bosch, F van den;
Yu, D. T;
Miller, A. S;
Reveille, J. D;
Caplan, L.
OBJECTIVE: To provide evidence-based recommendations for the treatment of patients with ankylosing spondylitis (AS) and nonradiographic axial spondyloarthritis (SpA). METHODS: A core group led the development of the recommendations, starting with the treatment questions. A literature review group conduct...
Pelvispondylite rhumatismale/traitement médicamenteux,
Spondylarthrite/traitement médicamenteux,
Anti-inflammatoires non stéroïdiens/usage thérapeutique,
Antirhumatismaux/usage thérapeutique,
Glucocorticoïdes/usage thérapeutique,
Facteur de nécrose tumorale alpha/usage thérapeutique,
Infliximab/usage thérapeutique,
Adalimumab/usage thérapeutique,
Étanercept/usage thérapeutique,
Techniques de physiothérapie,
Pelvispondylite rhumatismale/thérapie
Hingorani, A;
LaMuraglia, G. M;
Henke, P;
Meissner, M. H;
Loretz, L;
Zinszer, K. M;
Driver, V. R;
Frykberg, R;
Carman, T. L;
Marston, W;
Mills, J. L;
Murad, M. H.
Diabetes mellitus continues to grow in global prevalence and to consume an increasing amount of health care resources. One of the key areas of morbidity associated with diabetes is the diabetic foot. To improve the care of patients with diabetic foot and to provide an evidence-based multidisciplinary man...
Singh, JA;
Saag, KG;
Bridges Jr, SL;
Akl, EA;
Bannuru, RR;
Sullivan, MC;
Vaysbrot, E;
McNaughton, C;
Osani, M;
Shmerling, RH;
Curtis, JR;
Furst, DE;
Parks, D;
Kavanaugh, A;
O'Dell, J;
King, C;
Leong, A;
Matteson, EL;
Schousboe, JT;
Drevlow, B;
Ginsberg, S;
Grober, J;
St Clair, EW;
Tindall, E;
Miller, AS;
McAlindon, T.
OBJECTIVE:
To develop a new evidence-based, pharmacologic treatment guideline for rheumatoid arthritis (RA).
METHODS:
We conducted systematic reviews to synthesize the evidence for the benefits and harms of various treatment options. We used the Grading of Recommendations Assessment, Development and Eva...
Singh, J. A;
Saag, K. G;
Bridges Junior, S. L;
Akl, E. A;
Bannuru, R. R;
Sullivan, M. C;
Vaysbrot, E;
McNaughton, C;
Osani, M;
Shmerling, R. H;
Curtis, J. R;
Furst, D. E;
Parks, D;
Kavanaugh, A;
O'Dell, J;
King, C;
Leong, A;
Matteson, E. L;
Schousboe, J. T;
Drevlow, B;
Ginsberg, S;
Grober, J;
St Clair, E. W;
Tindall, E;
Miller, A. S;
McAlindon, T.
OBJECTIVE: To develop a new evidence-based, pharmacologic treatment guideline for rheumatoid arthritis (RA). METHODS: We conducted systematic reviews to synthesize the evidence for the benefits and harms of various treatment options. We used the Grading of Recommendations Assessment, Development and Eval...
Cardona, Victòria;
Cabañes, Nieves;
Chivato, Tomás;
De la Hoz, Belén;
Fernández Rivas, Montserrat;
Gangoiti Goikoetxea, Iker;
Guardia, Pedro;
Herranz Sanz, Miguel Ángel;
Juliá Benito, Juan Carlos;
Lobera Labairu, Teófilo;
Praena Crespo, Manuel;
Prieto Romo, José Ignacio;
Sánchez Salguero, Carlos;
Sánchez, José Ignacio;
Uixera Marzal, Sonia;
Vega, Arantza;
Villarroel, Pedro.
Esta nueva versión de GALAXIA está dirigida a todos los profesionales sanitarios, en todos los niveles de asistencia, para proporcionar recomendaciones en el manejo de la anafilaxia. La anafilaxia es la reacción alérgica más grave que puede ocurrir, e incluso puede llegar a poner en peligro la vida ...
The specific objectives were to evaluate the harms to benefits ratio of delamanid in combination with the currently recommended MDR-TB treatment regimen in children. Based on this evaluation, to develop recommendations on the use of delamanid as part of WHO-recommended longer MDR-TB treatment regimens, a...
In November 2015, the World Health Organization (WHO) convened a meeting of a Guideline Development Group (GDG) for the update of policy recommendations on the treatment of drug-resistant TB. The GDG was composed of a multidisciplinary group of tuberculosis (TB) and drug-resistant TB experts external to ...
Following the publication of Guidelines on certification of elimination of human onchocerciasis in 2001 by the World Health Organization (WHO), these are the first evidence-based guidelines developed by NTD Department according to the international standards. They provide a set of recommendations that wo...
This guideline provides global, evidence-informed recommendations on daily iron supplementation in infants and children, as a public-health intervention for the prevention of anaemia and iron deficiency. It includes recommendations for iron supplementation in countries where malaria is prevalent. The gui...
